Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs

Question 221: Which of the following poisons is NOT dialyzable?

A. Ethylene glycol
B. Methanol
C. Barbiturates
D. Copper sulphate (Correct Answer)

Explanation: **Explanation:** The dialyzability of a toxin depends on its physicochemical properties. For a substance to be effectively removed by hemodialysis, it must have a **low molecular weight**, **low protein binding**, **small volume of distribution (Vd)**, and **high water solubility**. **Why Copper Sulphate is the correct answer:** Copper sulphate is **not dialyzable** because it rapidly binds to plasma proteins (like albumin and ceruloplasmin) and sequesters into tissues (high Vd). Dialysis cannot remove substances that are heavily protein-bound or stored in tissues. Management of copper poisoning primarily involves gastric lavage and chelation therapy with **D-Penicillamine**. **Analysis of Incorrect Options:** * **Ethylene glycol & Methanol:** These are classic indications for hemodialysis. They are small, water-soluble molecules with low protein binding and low Vd. Dialysis is life-saving as it removes both the parent alcohol and its toxic acid metabolites (e.g., formic acid, oxalic acid). * **Barbiturates:** Long-acting barbiturates (like Phenobarbital) have low protein binding and low Vd, making them amenable to removal via hemodialysis or hemoperfusion. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Dialyzable poisons (BLAST-ED):** **B**arbiturates (long-acting), **L**ithium, **A**lcohols (Methanol/Ethylene glycol), **S**alicylates, **T**heophylline, **E**thylene glycol, **D**epakote (Valproate). * **Non-dialyzable poisons:** Copper sulphate, Digoxin, Benzodiazepines, Opioids, and Organophosphates (due to high Vd or high protein binding). * **Hemoperfusion** is superior to hemodialysis for highly protein-bound drugs like Carbamazepine and Theophylline.

Question 222: Bisphosphonates are prescribed to a patient with which of the following advice?

A. Take on an empty stomach with plenty of water. (Correct Answer)
B. Take after meals.
C. Discontinue if gastritis develops.
D. Discontinue if severe bone pain occurs.

Explanation: **Explanation:** **1. Why Option A is Correct:** Bisphosphonates (e.g., Alendronate, Risedronate) have extremely **poor oral bioavailability** (typically <1%). Their absorption is significantly further impaired by the presence of food, calcium, iron, or beverages other than plain water. Therefore, they must be taken on an **empty stomach** (at least 30 minutes before the first food or drink of the day) with a **full glass of plain water** to ensure adequate systemic absorption. **2. Why Other Options are Incorrect:** * **Option B:** Taking the drug after meals would render it almost entirely unabsorbed due to chelation with dietary cations and interference from food particles. * **Option C:** While bisphosphonates can cause esophageal irritation, mild gastritis is often managed by ensuring the patient remains upright for 30 minutes. Discontinuation is usually reserved for severe esophageal ulceration or strictures, not every instance of gastric upset. * **Option D:** Severe bone, joint, or muscle pain is a known side effect of bisphosphonates. While it may require clinical review, it is not a standard "advice" given at the start of therapy compared to the critical administration instructions. **High-Yield NEET-PG Clinical Pearls:** * **The "Upright" Rule:** Patients must remain upright (sitting or standing) for at least 30 minutes after ingestion to prevent **pill-induced esophagitis** and esophageal reflux. * **Mechanism of Action:** They inhibit **osteoclast-mediated bone resorption** by inducing osteoclast apoptosis. * **Key Side Effects:** 1. **Erosive Esophagitis** (most common clinical concern). 2. **Osteonecrosis of the Jaw (ONJ)** (associated with high-dose IV use/dental procedures). 3. **Atypical Subtrochanteric Fractures** (with long-term use). * **Drug of Choice:** Bisphosphonates are the first-line treatment for **Postmenopausal Osteoporosis** and **Paget’s disease**.

Question 223: Which antitubercular drug combination is safer in a patient who develops hepatitis while on ATT?

A. Streptomycin + Isoniazid
B. Streptomycin + Ethambutol (Correct Answer)
C. Ethambutol + Isoniazid
D. Ethambutol + Rifampicin

Explanation: ### Explanation **Core Concept: Hepatotoxicity of Antitubercular Therapy (ATT)** The standard first-line ATT regimen (HRZE) contains three drugs that are potentially hepatotoxic: **Isoniazid (H), Rifampicin (R), and Pyrazinamide (Z)**. Among these, Pyrazinamide is the most hepatotoxic, followed by Isoniazid and Rifampicin. When a patient develops drug-induced liver injury (DILI), all hepatotoxic drugs must be stopped. The safest alternatives are those that are not metabolized by the liver and do not cause hepatic damage. **Why Option B is Correct:** * **Streptomycin (S):** An aminoglycoside excreted unchanged by the kidneys. It has no known hepatotoxicity. * **Ethambutol (E):** Primarily excreted in the urine and is considered non-hepatotoxic. * Therefore, the combination of **Streptomycin + Ethambutol** is the safest "liver-sparing" regimen until the hepatitis resolves and hepatotoxic drugs can be reintroduced. **Why Other Options are Incorrect:** * **Options A & C:** Contain **Isoniazid**, which is a major cause of idiosyncratic hepatotoxicity. * **Option D:** Contains **Rifampicin**, which can cause cholestatic jaundice and potentiates the toxicity of Isoniazid. **NEET-PG High-Yield Pearls:** 1. **Management Protocol:** If ALT/AST levels rise >3 times the upper limit of normal (ULN) with symptoms, or >5 times ULN without symptoms, stop HRZ immediately. 2. **Reintroduction Sequence:** Once enzymes return to <2x ULN, drugs are reintroduced one by one: **Rifampicin first** (least toxic), followed by **Isoniazid** after 3–7 days. **Pyrazinamide** is usually the last to be added or may be avoided entirely if the reaction was severe. 3. **Safest Drug in Liver Disease:** Ethambutol and Streptomycin. 4. **Safest Drug in Renal Failure:** Rifampicin (as it is primarily excreted in bile). Avoid Streptomycin and Ethambutol (or adjust doses).

Question 224: All of the following are adverse effects of Tacrolimus EXCEPT:

A. Nephrotoxicity
B. Neurotoxicity
C. Hirsutism (Correct Answer)
D. Hyperglycemia

Explanation: **Explanation:** Tacrolimus is a **Calcineurin Inhibitor (CNI)**, widely used as a potent immunosuppressant in organ transplantation. While its mechanism of action is similar to Cyclosporine (binding to FKBP-12 to inhibit IL-2 production), their adverse effect profiles have distinct differences that are frequently tested in NEET-PG. **Why Hirsutism is the correct answer:** Hirsutism (excessive hair growth) and Gingival Hyperplasia are classic side effects of **Cyclosporine**, but they are notably **absent** with Tacrolimus. In fact, Tacrolimus is more likely to cause **Alopecia** (hair loss). Switching a patient from Cyclosporine to Tacrolimus is a common clinical strategy to manage cosmetic side effects like hirsutism. **Analysis of Incorrect Options:** * **Nephrotoxicity (A):** This is the most common and dose-limiting toxicity for both Tacrolimus and Cyclosporine. It occurs due to potent vasoconstriction of the afferent arterioles. * **Neurotoxicity (B):** Tacrolimus is significantly **more neurotoxic** than Cyclosporine. Patients may present with tremors (most common), headache, seizures, or paresthesia. * **Hyperglycemia (D):** Tacrolimus is more likely to cause **New-Onset Diabetes After Transplantation (NODAT)** compared to Cyclosporine, as it is more toxic to pancreatic beta cells. **High-Yield Clinical Pearls for NEET-PG:** * **Tacrolimus vs. Cyclosporine:** Tacrolimus has a higher incidence of Neurotoxicity and Hyperglycemia, but a lower incidence of Hirsutism and Gingival Hyperplasia. * **Monitoring:** Both drugs require **Therapeutic Drug Monitoring (TDM)** due to a narrow therapeutic index. * **Metabolism:** Both are metabolized by **CYP3A4**; avoid grapefruit juice as it increases drug levels.

Question 225: The clinical effects of Organophosphorous toxicity is due to inhibition of which enzyme?

A. RBC cholinesterase (Correct Answer)
B. Plasma cholinesterase
C. Neuropathy target esterase
D. All of the above

Explanation: **Explanation:** Organophosphorus (OP) compounds exert their toxicity primarily by irreversibly inhibiting **Acetylcholinesterase (AChE)**. This leads to an accumulation of acetylcholine at muscarinic and nicotinic receptors, resulting in a cholinergic crisis. **Why RBC Cholinesterase is the correct answer:** In the context of clinical effects and diagnosis, **RBC cholinesterase (True Cholinesterase)** is the same enzyme found at the neuromuscular junctions and neuronal synapses. Its inhibition directly reflects the degree of toxicity at the target tissues. It is more specific for OP poisoning and correlates better with the severity of clinical symptoms compared to plasma levels. **Analysis of Incorrect Options:** * **B. Plasma Cholinesterase (Butyrylcholinesterase/Pseudocholinesterase):** While this enzyme is inhibited *earlier* than RBC cholinesterase, it is synthesized in the liver and does not reflect the status of neuronal synapses. It is a sensitive marker for exposure but a poor indicator of clinical severity. * **C. Neuropathy Target Esterase (NTE):** Inhibition of this enzyme is responsible for **Organophosphate-Induced Delayed Polyneuropathy (OPIDP)**, which occurs 1–3 weeks after exposure. It does not cause the acute clinical effects (SLUDGE/DUMBELS) seen in OP toxicity. * **D. All of the above:** While OP compounds can inhibit multiple esterases, the acute "clinical effects" (cholinergic crisis) are specifically due to the inhibition of true cholinesterase. **High-Yield Clinical Pearls for NEET-PG:** * **Monitoring:** RBC cholinesterase levels are used to decide when to stop Oxime therapy. * **Management:** Atropine (physiological antagonist) treats muscarinic symptoms; Pralidoxime (enzyme reactivator) treats nicotinic symptoms if given before "aging" of the enzyme occurs. * **Intermediate Syndrome:** Occurs 24–96 hours after exposure due to persistent inhibition of AChE at the NMJ, leading to proximal muscle weakness and respiratory failure.

Question 226: All of the following are true statements EXCEPT:

A. Sirolimus acts by inhibiting the action of IL-2
B. Tacrolimus inhibits the calcineurin pathway
C. Mycophenolate acts by inhibiting GMP synthase (Correct Answer)
D. Cyclosporine is an integral component of transplant rejection regimens

Explanation: ### Explanation **1. Why Option C is the Correct Answer (The Exception)** Mycophenolate Mofetil (MMF) does not inhibit GMP synthase. Instead, it acts as a potent, reversible, non-competitive inhibitor of **Inosine Monophosphate Dehydrogenase (IMPDH)**. This enzyme is the rate-limiting step in the *de novo* synthesis of guanosine nucleotides (specifically converting IMP to XMP). Since T and B lymphocytes are uniquely dependent on the *de novo* pathway rather than the salvage pathway for purine synthesis, MMF selectively inhibits their proliferation. **2. Analysis of Other Options** * **Option A (Sirolimus):** This is a true statement. Sirolimus (Rapamycin) binds to FKBP-12 to form a complex that inhibits **mTOR** (mammalian Target of Rapamycin). This blocks the cell cycle progression from G1 to S phase, effectively inhibiting the **response/action** of IL-2 on T-cells. * **Option B (Tacrolimus):** This is a true statement. Tacrolimus (FK506) binds to FKBP-12, and this complex inhibits **calcineurin**. This prevents the dephosphorylation of NFAT (Nuclear Factor of Activated T-cells), thereby blocking the **production** of IL-2. * **Option D (Cyclosporine):** This is a true statement. Despite the rise of newer agents, Cyclosporine (a calcineurin inhibitor that binds to Cyclophilin) remains a cornerstone in various "triple-drug" immunosuppressive regimens for solid organ transplantation. **3. NEET-PG High-Yield Pearls** * **The "IL-2" Distinction:** Remember that **Tacrolimus/Cyclosporine** inhibit IL-2 *production*, whereas **Sirolimus** inhibits IL-2 *action*. * **Side Effect Profiles:** * **Cyclosporine:** Nephrotoxicity, Gingival hyperplasia, Hirsutism. * **Tacrolimus:** Nephrotoxicity, Neurotoxicity, Hyperglycemia (Post-transplant Diabetes). * **Sirolimus:** Hyperlipidemia, Thrombocytopenia (notably *not* nephrotoxic). * **Mycophenolate:** GI distress and Bone marrow suppression. * **IMPDH Isoforms:** MMF inhibits the **Type II isoform** of IMPDH, which is expressed primarily in activated lymphocytes.

Question 227: Maternal use of which of the following drugs can cause hypospadias in the baby?

A. Diethylstilbestrol
B. Tolbutamide
C. Clomiphene (Correct Answer)
D. Clobazam

Explanation: **Explanation:** **Clomiphene citrate** is a Selective Estrogen Receptor Modulator (SERM) used primarily for ovulation induction. While it is generally discontinued once pregnancy is confirmed, its use has been epidemiologically linked to an increased risk of **hypospadias** in male offspring. The underlying mechanism involves the drug's anti-estrogenic effect, which can interfere with the estrogen-androgen balance required for the normal fusion of the urethral folds during fetal development. **Analysis of Incorrect Options:** * **A. Diethylstilbestrol (DES):** Historically famous for causing **Clear Cell Adenocarcinoma of the vagina** in female offspring and structural abnormalities of the uterus (T-shaped uterus). In males, it is associated with cryptorchidism and epididymal cysts, but Clomiphene is the more specific association for hypospadias in this context. * **B. Tolbutamide:** A first-generation sulfonylurea. While poorly controlled maternal diabetes is teratogenic, tolbutamide itself is more commonly associated with prolonged neonatal hypoglycemia rather than specific structural defects like hypospadias. * **C. Clobazam:** A benzodiazepine used in epilepsy. Benzodiazepines are generally associated with "Floppy Infant Syndrome" or cleft lip/palate (though data is debated), but not specifically hypospadias. **NEET-PG High-Yield Pearls:** * **Hypospadias** is also associated with maternal exposure to **Finasteride** (5-alpha reductase inhibitors) and **Valproate**. * **Clomiphene** works by inhibiting the negative feedback of estrogen on the hypothalamus, leading to increased GnRH, FSH, and LH pulses. * Always remember the "DES Daughter" triad: Clear cell adenocarcinoma, T-shaped uterus, and infertility.

Question 228: A middle-aged woman with depression attempted suicide by taking a very high dose of amitriptyline. Which of the following statements regarding the management of this overdose is incorrect?

A. Atropine sulfate is the antidote of choice. (Correct Answer)
B. Diazepam is used to control seizures.
C. Sodium bicarbonate is used to treat acidosis.
D. Resuscitation may be required in severe cases.

Explanation: ### Explanation Amitriptyline is a **Tricyclic Antidepressant (TCA)**. TCA overdose is a common medical emergency characterized by the "3 Cs": **C**oma, **C**onvulsions, and **C**ardiotoxicity. **Why Option A is the Correct (Incorrect Statement):** Amitriptyline itself possesses potent **anticholinergic (atropine-like) properties**. It blocks muscarinic receptors, leading to symptoms like tachycardia, dry mouth, and dilated pupils. Administering **Atropine sulfate** would exacerbate this anticholinergic toxicity and worsen tachycardia. There is no specific "antidote" for TCA poisoning; management is primarily supportive. **Analysis of Other Options:** * **Option B:** TCAs lower the seizure threshold. **Diazepam** (or other benzodiazepines) is the first-line treatment for controlling TCA-induced seizures. * **Option C:** **Sodium bicarbonate (IV)** is the most critical intervention in TCA overdose. It serves two purposes: it treats metabolic acidosis and, more importantly, increases extracellular sodium to overcome the **fast sodium channel blockade** caused by TCAs, thereby narrowing the QRS complex and preventing arrhythmias. * **Option D:** Severe overdose leads to respiratory depression and cardiovascular collapse; thus, **resuscitation** (ABC management) and mechanical ventilation are often necessary. **High-Yield NEET-PG Pearls:** * **ECG Hallmark:** QRS prolongation (>100 ms) is a predictor of seizures; >160 ms is a predictor of ventricular arrhythmias. * **Sodium Bicarbonate Indication:** Used when QRS >120 ms or in the presence of life-threatening arrhythmias. * **Avoid:** Class IA and IC antiarrhythmics (e.g., Procainamide) as they worsen sodium channel blockade. * **Gastric Decontamination:** Activated charcoal is effective if the patient presents within 1–2 hours.

Question 229: Amphetamine use during pregnancy is associated with which of the following fetal complications?

A. Intrauterine growth restriction (IUGR)
B. Cardiac anomalies
C. Cleft lip
D. All of the above (Correct Answer)

Explanation: **Explanation:** Amphetamines are potent sympathomimetic amines that act as central nervous system stimulants. When used during pregnancy, they cross the placenta and exert significant vasoconstrictive effects on both maternal and fetal vasculature. **1. Why "All of the above" is correct:** The primary mechanism of amphetamine-induced teratogenicity is **fetal hypoxia and ischemia** caused by placental vasoconstriction and maternal hypertension. * **Intrauterine Growth Restriction (IUGR):** Chronic vasoconstriction reduces uterine blood flow, leading to decreased nutrient and oxygen delivery to the fetus, resulting in low birth weight and IUGR. * **Cardiac Anomalies:** Exposure during the first trimester (organogenesis) is linked to structural defects, most notably atrial and ventricular septal defects. * **Cleft Lip/Palate:** Vascular disruption during facial development increases the risk of orofacial clefts. **2. Analysis of Options:** While each option (A, B, and C) represents a specific complication, they are not mutually exclusive. Epidemiological studies and clinical data confirm that amphetamine abuse is associated with a spectrum of structural malformations and growth disturbances, making "All of the above" the most accurate clinical choice. **3. NEET-PG High-Yield Pearls:** * **Mechanism:** Amphetamines increase the release of catecholamines (Dopamine, NE, Serotonin) and inhibit their reuptake. * **Neonatal Behavioral Syndrome:** Infants born to users may exhibit "methamphetamine withdrawal," characterized by irritability, tremors, and poor feeding. * **Other Complications:** Increased risk of placental abruption, preterm labor, and intracranial hemorrhage in the neonate. * **Comparison:** Unlike Cocaine (which is also a vasoconstrictor), Amphetamines have a longer half-life, potentially leading to prolonged fetal exposure.

Question 230: Which of the following is not a side effect of naloxone?

A. Seizure (Correct Answer)
B. Hypertension
C. Pulmonary edema
D. Ventricular dysrhythmia

Explanation: **Explanation:** **Naloxone** is a competitive opioid antagonist used primarily for the emergency reversal of opioid overdose. Understanding its side effect profile is crucial for NEET-PG, as most adverse effects are related to **acute opioid withdrawal** rather than direct drug toxicity. **Why Seizure is the Correct Answer:** Naloxone itself does not lower the seizure threshold. While opioid withdrawal can cause significant autonomic instability, it is **not** typically associated with seizures. In contrast, withdrawal from sedative-hypnotics (like benzodiazepines or alcohol) is characterized by seizures. Therefore, seizures are not a recognized side effect of naloxone administration. **Analysis of Incorrect Options (Side Effects of Naloxone):** When naloxone rapidly displaces opioids from receptors in a dependent patient, it triggers a massive surge in catecholamines (Sympathetic Overdrive). This leads to: * **Hypertension (Option B):** Sudden reversal causes a "stress response," leading to a sharp rise in blood pressure. * **Pulmonary Edema (Option C):** This is a rare but classic "high-yield" complication. It is thought to be **non-cardiogenic**, resulting from the sudden catecholamine surge and changes in intrathoracic pressure. * **Ventricular Dysrhythmia (Option D):** Increased adrenaline and noradrenaline levels can precipitate tachycardia, ventricular fibrillation, or other arrhythmias, especially in patients with underlying cardiac disease. **NEET-PG High-Yield Pearls:** * **Mechanism:** Pure competitive antagonist at $\mu$, $\kappa$, and $\delta$ receptors (highest affinity for $\mu$). * **Route:** Given IV, IM, or Intranasal. It has poor oral bioavailability due to high first-pass metabolism. * **Duration of Action:** 30–90 minutes. This is often **shorter** than the opioid being reversed (e.g., Methadone), necessitating repeated dosing or infusion to prevent "re-narcotization." * **Clinical Sign:** The most immediate sign of successful reversal is an increase in respiratory rate.

Practice by Chapter

Principles of Clinical Pharmacology

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Drug Toxicity and Overdose

Practice Questions

Antidotes and Their Applications

Practice Questions

Management of Drug Poisoning

Practice Questions

Drug-Induced Liver Injury

Practice Questions

Drug-Induced Kidney Injury

Practice Questions

Drug-Induced Blood Dyscrasias

Practice Questions

Drug-Induced QT Prolongation

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free